A share price of MBX Biosciences Inc [MBX] is currently trading at $18.96, down -5.20%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MBX shares have gain 94.56% over the last week, with a monthly amount glided 32.31%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Mizuho started tracking the stock with Outperform rating on August 05, 2025, and set its price target to $38. On July 16, 2025, Oppenheimer initiated with a Outperform rating and assigned a price target of $38 on the stock. Citizens JMP started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $38 on April 10, 2025. Stifel initiated its recommendation with a Buy and recommended $40 as its price target on October 08, 2024. JP Morgan started tracking with a Overweight rating for this stock on October 08, 2024, and assigned it a price target of $30. In a note dated October 08, 2024, Jefferies initiated a Buy rating and provided a target price of $35 on this stock.
MBX Biosciences Inc experienced fluctuations in its stock price throughout the past year between $4.81 and $27.50. Currently, Wall Street analysts expect the stock to reach $38 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $18.96 at the most recent close of the market. An investor can expect a potential return of 100.42% based on the average MBX price forecast.
Analyzing the MBX fundamentals
Gross Profit Margin for this corporation currently stands at -0.75% with Operating Profit Margin at -389.89%, Pretax Profit Margin comes in at -346.93%, and Net Profit Margin reading is -346.93%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.31 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.91 points at the first support level, and at 16.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.65, and for the 2nd resistance point, it is at 22.34.
Ratios To Look Out For
To put it in perspective, the Current Ratio for MBX Biosciences Inc [NASDAQ:MBX] is 19.50. Further, the Quick Ratio stands at 19.50, while the Cash Ratio is 3.38.
Transactions by insiders
Recent insider trading involved Pescovitz Ora H., Director, that happened on Apr 08 ’25 when 7693.0 shares were purchased. Director, GORDON CARL L completed a deal on Feb 18 ’25 to buy 0.14 million shares. Meanwhile, Director GORDON CARL L bought 47502.0 shares on Feb 14 ’25.
